Circuit Clinical operates an integrated research organization (IRO) and patient engagement business that connects physicians, sites, and patients to clinical research. The company has a network representing over 90 doctors across more than 30 site locations, a nationally accredited cancer center, and a database of more than 2.5 million potential trial participants. Its offering includes an award-winning patient engagement platform, TrialJourney, and spans 10 therapeutic areas including oncology, cardiovascular disease, diabetes, women’s health, and others. Circuit Clinical positions clinical research as a care option and focuses on improving retention, decreasing patient burden, and enhancing the patient experience. As part of a new strategic partnership, all Circuit Clinical sites will be standardized on Medidata’s RAVE and myMedidata technology solutions to enable turnkey decentralized and hybrid trial programs. The company plans to expand its decentralized clinical trial (DCT) network to 500 physician investigators and reach 15 million patients through the partnership. Medidata’s strategic investment in Circuit Clinical’s $27M Series C will fund that expansion and technology integration. Circuit Clinical is an integrated research organization (IRO) headquartered in Buffalo, NY that began conducting clinical research within physicians' practices in 2015. It partners with a multi-specialty network of physician practices and multiple Accountable Care Organizations to offer patients access to clinical trials in their own doctors' offices. Its core product, TrialScout™, is a ratings-and-reviews platform and patient-facing trial finder designed to help patients find, choose, and rate clinical trial experiences. The company combines technology-enabled services with in-office research teams to rapidly find and enroll the right patients and support retention through study completion. As a 43North 2019 competition winner, Circuit Clinical received a $500,000 cash investment and one year of free incubator space, plus mentorship, investor-network access, and marketing and hiring support. The company is positioning to transform the patient experience of finding and participating in clinical trials through its platform and service model.

Total raised

$28M

Funding rounds

2

Latest round

Series C

Latest activity

Jan 2022